Notably, IL-13 CSF levels were also associated with reduced measures of neuronal and axonal damage and with increased amyloid-beta CSF concentrations, suggesting a protective role of this cytokine in MS (120). This evidence concerns the gene IL13 and myeloid sarcoma.